Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 7;10(1):e032379.
doi: 10.1136/bmjopen-2019-032379.

Efficacy of adjunctive azithromycin versus single-dose cephalosporin prophylaxis for caesarean scar defect: study protocol for a randomised controlled trial

Yanqing Cai  1 , Hongjie Pan  1   2 , Jian Zhang  1 , Weiwei Cheng  1 , Yiru Shi  1 , Min Zeng  3 , Liye Shi  3 , Jin Yu  1 , Ying Shen  1 , Shan Chen  1 , Qian Zhu  1 , Ben W Mol  4   5 , Ding Huang  6
Affiliations

Efficacy of adjunctive azithromycin versus single-dose cephalosporin prophylaxis for caesarean scar defect: study protocol for a randomised controlled trial

Yanqing Cai et al. BMJ Open. .

Abstract

Introduction: Perioperative infections may be considered predictors of caesarean scar defect (CSD), and multidose antibiotics have a protective effect against CSD. However, the ability of adjunctive azithromycin combined with cephalosporin to reduce the prevalence of CSD remains unclear. The planned study aims to clarify the protective effect of antibiotics against CSD and to assess the effectiveness of adjunctive azithromycin prophylaxis for CSD.

Methods and analysis: This study is a double-blind, parallel-control randomised clinical trial that will be carried out at the International Peace Maternity and Child Health Hospital. A total of 220 eligible patients will be randomised (1:1) to receive either adjunctive azithromycin or single-dose cephalosporin 30 min before the incision. The evaluation criteria are the prevalence and characteristics of CSD as assessed by transvaginal ultrasound (TVU) and saline infusion sonohysterography (SIS) at 42 days, 6 months and 12 months after delivery. The primary outcome will be the prevalence of CSD, and the characteristics of CSD will be assessed by TVU and SIS 42 days after delivery; all other outcomes are secondary.

Ethics and dissemination: This protocol received authorisation from the Medical Research Ethics Committee of International Peace Maternity and Child Health Hospital on 25 April 2018 (approval no. GKLW2017-84). The findings will be reported in peer-reviewed publications and presentations at international scientific meetings.

Trial registration number: ChiCTR-INR-17013272.

Keywords: antibiotic; azithromycin; caesarean scar defect; caesarean section; randomised control trial.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flowchart of the study. CS, caesarean section; TVUS, transvaginal ultrasonography.
See this image and copyright information in PMC

References

    1. Betrán AP, Ye J, Moller A-B, et al. . The increasing trend in caesarean section rates: global, regional and national estimates: 1990-2014. PLoS One 2016;11:e0148343 10.1371/journal.pone.0148343 - DOI - PMC - PubMed
    1. Tower AM, Frishman GN. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol 2013;20:562–72. 10.1016/j.jmig.2013.03.008 - DOI - PubMed
    1. Di Spiezio Sardo A, Saccone G, McCurdy R, et al. . Risk of Cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol 2017;50:578–83. 10.1002/uog.17401 - DOI - PubMed
    1. Allornuvor GFN, Xue M, Zhu X, et al. . The definition, aetiology, presentation, diagnosis and management of previous caesarean scar defects. J Obstet Gynaecol 2013;33:759–63. 10.3109/01443615.2013.816663 - DOI - PubMed
    1. Sholapurkar SL. Etiology of cesarean uterine scar defect (niche): detailed critical analysis of hypotheses and prevention strategies and peritoneal closure debate. J Clin Med Res 2018;10:166–73. 10.14740/jocmr3271w - DOI - PMC - PubMed

Publication types

MeSH terms